Bausch Health(BHC) ZACKS·2025-02-12 16:06Core Viewpoint - Bausch Health (BHC) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending December 2024, with actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The consensus estimate for Bausch's quarterly earnings is 2.51 billion, representing a 4.3% increase from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 0.75% higher, indicating a collective reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate for Bausch is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.74%, indicating a bearish outlook from analysts [10][11]. Historical Performance - In the last reported quarter, Bausch exceeded the expected earnings of 1.12, achieving a surprise of +8.74%. Over the past four quarters, the company has beaten consensus EPS estimates twice [12][13]. Investment Considerations - Despite the potential for an earnings beat, Bausch does not appear to be a compelling candidate for such an outcome, and investors should consider other factors before making investment decisions [14][16].